Herbas VPB

Print
EN | LT
LT - TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
EN - TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17 (2006.01)
A61K 38/1709 (2013.01)
A61K 39/395 (2006.01)
A61K 38/1793 (2013.01)
A61K 47/68 (2017.01)
A61K 39/395 (2013.01)
A61P 9/00 (2006.01)
A61K 47/68 (2017.08)
A61P 29/00 (2006.01)
A61K 47/6811 (2017.08)
A61K 38/20 (2006.01)
A61P 9/00 (2018.01)
A61K 38/2006 (2013.01)
European patent
(11) Number of the document 3687562
(13) Kind of document T
(96) European patent application number 18786587.8
Date of filing the European patent application 2018-09-26
(97) Date of publication of the European application 2020-08-05
(45) Date of publication and mention of the grant of the patent 2025-03-19
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/052985
Date 2018-09-26
PCT application publication
(87) Number WO 2019/067639
Date 2019-04-04
Priority applications
(30) Number Date Country code
201762563387 P 2017-09-26 US
201862616819 P 2018-01-12 US
201862625075 P 2018-02-01 US
201862639425 P 2018-03-06 US
201862654291 P 2018-04-06 US
201862691552 P 2018-06-28 US
201862716331 P 2018-08-08 US
Inventors
(72)
TESSARI, Eben , US
PAOLINI, John , US
Grantee
(73) Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Title
(54) TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
  TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN